| Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India TP Anand, AW Bhat, YS Shouche, U Roy, J Siddharth, SP Sarma Microbiological research 161 (3), 252-262, 2006 | 249 | 2006 |
| Biodegradation of tributyltins (organotins) by marine bacteria SK Dubey, U Roy Applied Organometallic Chemistry 17 (1), 3-8, 2003 | 187 | 2003 |
| Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages AS Nowacek, S Balkundi, JE McMillan, U Roy, A Martinez-Skinner, ... Journal of controlled release 150 (2), 204-211, 2011 | 125 | 2011 |
| Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ... Aids 26 (17), 2135-2144, 2012 | 121 | 2012 |
| Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers A Kaushik, RD Jayant, R Nikkhah-Moshaie, V Bhardwaj, U Roy, Z Huang, ... Scientific reports 6 (1), 25309, 2016 | 113 | 2016 |
| Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides AD Raymond, P Diaz, S Chevelon, M Agudelo, A Yndart-Arias, H Ding, ... Journal of neurovirology 22, 129-139, 2016 | 103 | 2016 |
| MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells M Eilers, U Roy, D Mondal Experimental biology and medicine 233 (9), 1149-1160, 2008 | 97 | 2008 |
| Characterization of nanodiamond-based anti-HIV drug delivery to the brain U Roy, V Drozd, A Durygin, J Rodriguez, P Barber, V Atluri, X Liu, ... Scientific reports 8 (1), 1603, 2018 | 93 | 2018 |
| PCL-PEG copolymer based injectable thermosensitive hydrogels MR Dethe, A Prabakaran, H Ahmed, M Agrawal, U Roy, A Alexander Journal of Controlled Release 343, 217-236, 2022 | 79 | 2022 |
| Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy N Gautam, U Roy, S Balkundi, P Puligujja, D Guo, N Smith, XM Liu, ... Antimicrobial agents and chemotherapy 57 (7), 3110-3120, 2013 | 75 | 2013 |
| Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ... The Journal of infectious diseases 206 (10), 1577-1588, 2012 | 71 | 2012 |
| Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells GD Kanmogne, S Singh, U Roy, X Liu, JE McMillan, S Gorantla, ... International journal of nanomedicine, 2373-2388, 2012 | 64 | 2012 |
| Comparative manufacture and cell-based delivery of antiretroviral nanoformulations S Balkundi, AS Nowacek, RS Veerubhotla, H Chen, A Martinez-Skinner, ... International journal of nanomedicine, 3393-3404, 2011 | 62 | 2011 |
| The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials U Roy, J Rodríguez, P Barber, J das Neves, B Sarmento, M Nair Nanomedicine 10 (24), 3597-3609, 2015 | 57 | 2015 |
| UPLC–MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues J Huang, N Gautam, SPR Bathena, U Roy, JE McMillan, HE Gendelman, ... Journal of Chromatography B 879 (23), 2332-2338, 2011 | 47 | 2011 |
| Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue U Roy, H Ding, S Pilakka-Kanthikeel, AD Raymond, V Atluri, A Yndart, ... International journal of nanomedicine, 5819-5835, 2015 | 36 | 2015 |
| Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection TZ Nazari-Shafti, E Freisinger, U Roy, CT Bulot, C Senst, CL Dupin, ... Retrovirology 8, 1-12, 2011 | 34 | 2011 |
| Montelukast is a potent and durable inhibitor of multidrug resistance protein 2 (MRP2)-mediated efflux of taxol and saquinavir U Roy, G Chakravarty, KH Zu Bentrup, D Mondal Biological & pharmaceutical bulletin 32 (12), 2002-09, 2009 | 33 | 2009 |
| Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir U Roy, C Bulot, K Honer zu Bentrup, D Mondal PloS one 8 (10), e75374, 2013 | 32 | 2013 |
| Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV‐1 infected monocytic cells SL Gerlach, M Yeshak, U Göransson, U Roy, R Izadpanah, D Mondal Peptide Science 100 (5), 471-479, 2013 | 29 | 2013 |
Larisa PoluektovaUniversity of Nebraska Medical CenterVerified email at unmc.edu
